Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael F Flessner

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|September 6, 2014
Pharmacokinetic assessment in patients receiving continuous RRT: perspectives from the Kidney Health InitiativeThomas D Nolin, George R Aronoff, William H Fissell, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 5, 2013
Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional studyDana C Miskulin, Kaleab Z Abebe, Arlene B Chapman, et al.
Current Hypertension Reviews|March 23, 2018
Determinants of Progression in Early Autosomal Dominant Polycystic Kidney Disease: Is it Blood Pressure or Renin-Angiotensin-Aldosterone-System Blockade?Godela M Brosnahan, Kaleab Z Abebe, Charity G Moore, et al.
Kidney International|December 21, 2016
Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney diseaseVicente E Torres, Kaleab Z Abebe, Robert W Schrier, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 30, 2015
Prevalence and Correlates of CKD in Hispanics/Latinos in the United StatesAna C Ricardo, Michael F Flessner, John H Eckfeldt, et al.
Journal of the American Society of Nephrology : JASN|December 19, 2019
A Randomized Trial Comparing the Safety, Adherence, and Pharmacodynamics Profiles of Two Doses of Sodium Bicarbonate in CKD: the BASE Pilot TrialKalani L Raphael, Tamara Isakova, Joachim H Ix, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 8, 2018
Patterns of Kidney Function Decline in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis From the HALT-PKD TrialsGodela M Brosnahan, Kaleab Z Abebe, Charity G Moore, et al.
The New England Journal of Medicine|November 18, 2014
Angiotensin blockade in late autosomal dominant polycystic kidney diseaseVicente E Torres, Kaleab Z Abebe, Arlene B Chapman, et al.
Physiological Genomics|December 22, 2011
Heritability of serum sodium concentration: evidence for sex- and ethnic-specific effectsBeth Wilmot, V Saroja Voruganti, Yen-Pei C Chang, et al.
The New England Journal of Medicine|November 18, 2014
Blood pressure in early autosomal dominant polycystic kidney diseaseRobert W Schrier, Kaleab Z Abebe, Ronald D Perrone, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Clinical Journal of the American Society of Nephrology : CJASN|September 6, 2014
Pharmacokinetic assessment in patients receiving continuous RRT: perspectives from the Kidney Health InitiativeThomas D Nolin, George R Aronoff, William H Fissell, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 5, 2013
Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional studyDana C Miskulin, Kaleab Z Abebe, Arlene B Chapman, et al.
Current Hypertension Reviews|March 23, 2018
Determinants of Progression in Early Autosomal Dominant Polycystic Kidney Disease: Is it Blood Pressure or Renin-Angiotensin-Aldosterone-System Blockade?Godela M Brosnahan, Kaleab Z Abebe, Charity G Moore, et al.
Kidney International|December 21, 2016
Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney diseaseVicente E Torres, Kaleab Z Abebe, Robert W Schrier, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 30, 2015
Prevalence and Correlates of CKD in Hispanics/Latinos in the United StatesAna C Ricardo, Michael F Flessner, John H Eckfeldt, et al.
Journal of the American Society of Nephrology : JASN|December 19, 2019
A Randomized Trial Comparing the Safety, Adherence, and Pharmacodynamics Profiles of Two Doses of Sodium Bicarbonate in CKD: the BASE Pilot TrialKalani L Raphael, Tamara Isakova, Joachim H Ix, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 8, 2018
Patterns of Kidney Function Decline in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis From the HALT-PKD TrialsGodela M Brosnahan, Kaleab Z Abebe, Charity G Moore, et al.
The New England Journal of Medicine|November 18, 2014
Angiotensin blockade in late autosomal dominant polycystic kidney diseaseVicente E Torres, Kaleab Z Abebe, Arlene B Chapman, et al.
Physiological Genomics|December 22, 2011
Heritability of serum sodium concentration: evidence for sex- and ethnic-specific effectsBeth Wilmot, V Saroja Voruganti, Yen-Pei C Chang, et al.
The New England Journal of Medicine|November 18, 2014
Blood pressure in early autosomal dominant polycystic kidney diseaseRobert W Schrier, Kaleab Z Abebe, Ronald D Perrone, et al.
Pageof 8